Cluster analyses from the real-world NOVELTY study : six clusters across the asthma COPD spectrum

Hughes, RodRapsomaniki, EleniBansal, Aruna TVestbo, JørgenPrice, DavidAgusti, AlvarBeasley, RichardAlacqua, MariannaPapi, AlbertoMüllerová, HanaReddel, Helen K.NOVELTY Scientific Community2023-09-132023-09-132023-09Hughes, R, Rapsomaniki, E, Bansal, A T, Vestbo, J, Price, D, Agusti, A, Beasley, R, Alacqua, M, Papi, A, Müllerová, H, Reddel, H K & NOVELTY Scientific Community 2023, 'Cluster analyses from the real-world NOVELTY study : six clusters across the asthma COPD spectrum', The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 9, pp. 2803-2811. https://doi.org/10.1016/j.jaip.2023.05.0132213-2198https://hdl.handle.net/2164/21659Funding The NOVELTY study is funded by AstraZeneca. ACKNOWLEDGMENTS The authors would like to thank the patients who participated in this study and the NOVELTY Scientific Community and the NOVELTY study investigators who are listed in full in Tables E7 and E8 in the Online Repository. Medical writing support, under the direction of the authors, was provided by Richard Knight, PhD, CMC Connect, a division of IPG Health Medical Communications, funded by AstraZeneca in accordance with Good Publication Practice (GPP 2022) guidelines (Ann Intern Med. 2022;175[9]:1298-1304). J. Vestbo is supported by the NIHR Manchester Biomedical Research Centre and the NIHR Manchester Clinical Research Facility9384053engPrecision medicineasthmabiomarkerschronic obstructive pulmonary diseasecluster analysisR MedicineNational Institute for Health Research (NIHR)RCluster analyses from the real-world NOVELTY study : six clusters across the asthma COPD spectrumJournal article10.1016/j.jaip.2023.05.013119